$ARNA Recent News Arena shares surge as marketer doubles

New Post Public Reply Private Reply Replies (0) Message Board

Nov 8, 2013 at 4:41 PM

$ARNA Recent News

Arena shares surge as marketer doubles sales force for diet drug

11:41 a.m. Oct. 15, 2013

- Russ Britt

Obesity drug makers jockey for position as analysts praise Vivus

12:06 p.m. Oct. 3, 2013

- Russ Britt

Hedge funds are buying these stocks right now

1:46 p.m. July 23, 2013

- Insider Monkey

5 stocks insiders are buying

1:52 p.m. June 7, 2013

- Insider Monkey

6 gut checks before the stock market's opening bell

6:47 a.m. March 7, 2013

- Shawn Langlois

Stocks to watch Monday: Transocean, Stratasys

9:22 a.m. March 4, 2013

- Sue Chang

Arena Pharmaceuticals down 7.4% in premarket

9:11 a.m. Jan. 22, 2013

- Steve Gelsi

What 2012’s winners and losers say about 2013

6:00 a.m. Dec. 14, 2012

- Howard Gold

6 gut checks before the stock market's opening bell

6:50 a.m. Dec. 12, 2012

- Shawn Langlois

4 charts challenging resistance

7:06 a.m. Oct. 16, 2012

- The Trading Deck

Vivus sees EU regulators rejecting diet drug

12:16 p.m. Sept. 21, 2012

- MarketWatch.com

Vivus falls 11% on EU drug approval update

11:07 a.m. Sept. 21, 2012

- Val Brickates Kennedy

Arena rises as Vivus sees anti-obesity setback

7:49 a.m. Sept. 21, 2012

- Greg Morcroft

Vivus says Europe likely to reject obesity drug

7:33 a.m. Sept. 21, 2012

- MarketWatch.com

Orexigen soars 19% on analyst buy rating

12:46 p.m. Sept. 6, 2012

- Val Brickates Kennedy

Arena jumps 12% amid takeover speculation

1:55 p.m. Aug. 14, 2012

- Val Brickates Kennedy

Arena trips Nasdaq short-sale circuit breaker

3:01 p.m. Aug. 1, 2012

- Val Brickates Kennedy

Arena Pharma share drop trips short-sale limit

2:16 p.m. Aug. 1, 2012

- Laura Mandaro

Eisai gears up for launch of Arena's diet drug

9:32 a.m. July 30, 2012

- Val Brickates Kennedy

Apple, Arena active; Lumber Liquidators at new high

9:06 a.m. July 25, 2012

- blogs.marketwatch.com

VIVUS Loss In Line with Ests, Shares Fall - Analyst Blog

4:45 p.m. Nov. 7, 2013

- Zacks.com

Arena Pharmaceuticals, Eisai Expand Marketing and Supply Agreement for BELVIQ

3:03 p.m. Nov. 7, 2013

- benzinga.com

Arena's Belviq Refills - Week 20

12:43 a.m. Nov. 5, 2013

- Seeking Alpha

Arena Pharmaceuticals - Belviq OTC?

3:09 a.m. Nov. 4, 2013

- Seeking Alpha

Arena's Belviq - Week 20 Sales Data

1:28 p.m. Nov. 1, 2013

- Seeking Alpha

Arena Stock Reacts To Eisai Quarterly Call

10:26 a.m. Nov. 1, 2013

- Seeking Alpha

Should You Worry About the Short Interest in Arena Pharmaceuticals, Inc. (ARNA)? - Tale of the Tape

9:59 a.m. Nov. 1, 2013

- Zacks.com

Benzinga's Top #PreMarket Losers

7:13 a.m. Nov. 1, 2013

- benzinga.com

Uh Oh Arena Pharma! Q3 Belviq Sales Just $4.8M

7:09 a.m. Nov. 1, 2013

- TheStreet.com

A Look Back At Biotech Short Picks

2:18 p.m. Oct. 31, 2013

- Seeking Alpha

Interesting ARNA Put And Call Options For December 6th

10:46 a.m. Oct. 31, 2013

- TheStreet.com

Arena's Belviq Refills Week 19

3:29 a.m. Oct. 30, 2013

- Seeking Alpha

Latent Disconnect Between Arena's Fundamentals And Valuation

3:33 p.m. Oct. 29, 2013

- Seeking Alpha

Arena's Belviq Sales: Week 19

11:19 a.m. Oct. 25, 2013

- Seeking Alpha

November 29th Options Now Available For Arena Pharmaceuticals (ARNA)

11:15 a.m. Oct. 24, 2013

- TheStreet.com

Arena's Belviq Refills - Week 18 Data

4:26 p.m. Oct. 22, 2013

- Seeking Alpha

Arena's Belviq Sales Flat - Equity Holds

11:11 a.m. Oct. 18, 2013

- Seeking Alpha

Arena Pharmaceuticals, Inc. Enters Oversold Territory - Tale of the Tape

6:01 a.m. Oct. 18, 2013

- Zacks.com

Arena to Double Belviq Sales Force - Analyst Blog

12:50 p.m. Oct. 16, 2013

- Zacks.com

Arena Confirms Larger Sales Force For Belviq

2:51 p.m. Oct. 15, 2013

- Seeking Alpha

Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2013 Financial Results

4:10 p.m. Nov. 7, 2013

- PR Newswire

Arena Pharmaceuticals and Eisai Expand Marketing and Supply Agreement for BELVIQ® (lorcaserin HCl) to Include Most Countries Worldwide

4:02 p.m. Nov. 7, 2013

- PR Newswire

FDA Approvals, Successful Product Launches, Upcoming Earnings Schedules and Quarterly Financial Results - Research Report on Pfizer, Mettler-Toledo, Arena, Wright Medical, and Ophthotech

8:00 a.m. Nov. 7, 2013

- PR Newswire

Must Watch Stock News: Arena Pharmaceuticals, Hewlett-Packard Company, Resorts International, Alpha Natural Resources, Chevron Corporation

1:56 p.m. Nov. 4, 2013

- PR Newswire

Pre-Market Review: Arena Pharma Inc., Geron Corp., Incyte Corp. Ltd, and Spectrum Pharma Inc.

9:00 a.m. Oct. 31, 2013

- PR Newswire

Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, November 7

8:00 a.m. Oct. 30, 2013

- PR Newswire

Sales Strategies, Upcoming Financial Results Schedules, Clinical Study Updates, and FDA Agreements - Research Report on Arena, Seattle Genetics, Halozyme, Insmed, and Omeros

8:00 a.m. Oct. 21, 2013

- PR Newswire

Arena Pharmaceuticals Reports That Eisai Will Double BELVIQ® (lorcaserin HCl) CIV Sales Force by December

9:03 a.m. Oct. 15, 2013

- PR Newswire

Early Briefing and Review: Arena Pharma Inc., Spectrum Pharma Inc., Incyte Corp. Ltd., and Geron Corp.

9:26 a.m. Oct. 8, 2013

- PR Newswire

Drug Approvals, Data Presentations, Conferences, Increased Funding, and Merger Agreements - Research Report on Theravance, Arena, Exelixis, Verenium, and Enanta

8:00 a.m. Sept. 25, 2013

- PR Newswire

Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference

8:00 a.m. Sept. 23, 2013

- PR Newswire

Arena Pharmaceuticals to Present Clinical Data for BELVIQ® (lorcaserin HCl) CIV at the 49th Annual Meeting of the European Association for the Study of Diabetes (EASD)

8:00 a.m. Sept. 18, 2013

- PR Newswire

Arena Pharmaceuticals Provides Update as Eisai's Launch of BELVIQ® (lorcaserin HCl) CIV Enters Consumer Phase

8:00 a.m. Sept. 16, 2013

- PR Newswire

Track Insider Trading in Facebook, Zynga, Arena Pharmaceuticals, Lululemon Athletica, Weatherford International, and Bank of America

8:55 a.m. Sept. 13, 2013

- PR Newswire

Wall Street Fundamentals Releases New In-Depth Stock Reports on ARIA, ARNA, EXEL and OREX

9:05 a.m. Sept. 11, 2013

- ACCESSWIRE

Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch Global Healthcare Conference

8:00 a.m. Sept. 6, 2013

- PR Newswire

Successful Clinical Trials, Data Presentations, Promising Studies, Fulfilled Agreements and Investors Conferences - Research Report on Arena, BioMarin, Clovis Oncology, MannKind, and Medivation

8:00 a.m. Sept. 3, 2013

- PR Newswire

Five Star Equities Issues New Research Reports on ARNA, COCO, CWST and GES

8:40 a.m. Aug. 30, 2013

- ACCESSWIRE

Arena Pharmaceuticals Completes Phase 1b Clinical Trial Evaluating APD811 for Pulmonary Arterial Hypertension

8:00 a.m. Aug. 28, 2013

- PR Newswire

Innovus Pharma Provides Corporate Update

6:30 a.m. Aug. 19, 2013

- GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Investcorp's Strong 2026: A Deep Dive into Key Moves

Diving into Investcorp's Robust 2026 Performance If you're clued into the investment scene, you'll know that a $65.2 billion asset base isn't small potatoes. At the Gateway Gulf 2026, Investcorp didn't just present numbers—they laid out a dramatic year of action packed with billion-dollar dreams. While the dust hasn't quite settled yet, the first nine months of the year...

SICO Snags $1.6B in New Investor Mandates for 2026

SICO Makes Waves with Massive New Business Wins Right out of the gate at the Gateway Gulf 2026 Forum, SICO's announcement of a whopping $1.6 billion in new business mandates had even the seasoned pros raising an eyebrow or two. There's nothing like a sweet billion-dollar figure to kickstart the day, huh? This isn't small change we're talking about; this is a tidal wave of...

Perion Acquisition: Affle's Bold Leap in Ad Tech

Affle's Strategic Acquisition of Perion Jumpin' through another hoop, Affle is gearing up to snag Perion in a hefty deal valued at about $420 million. For those of you not knee-deep in the ad tech sandbox, Affle—trading on the NSE as AFFLE—is aiming to ramp up its AI-driven conversion game by absorbing Perion, a veteran in the omnichannel advertising realm. "This...

Can AI Help Climate? Tech Investments Seek Balance

Is AI a Climate Savior or a Power-Hungry Beast? AI might feel like that unpredictable family member you hope shows up to the party with something useful, but they’ve always got high energy bills. As the tech world touts artificial intelligence as the next big hope for addressing climate woes, folks like Peter Gilmer—who's been around a few boardrooms—are taking a...

Ensuring Flooring Stability: Acclimation's Key Role

Dive into the World of Flooring Acclimation You ever hear about flooring acclimation? Sounds as riveting as watching paint dry, right? But Austin J. Messina from Salem, New Hampshire, is here to tell us it's the secret to flooring that doesn't buckle under pressure—literally. Messina's insights, splashed across the pages of HelloNation, delve deep into the nitty-gritty...

Decoding LRV: Smart Paint Choices for Your Home

Unraveling the Secrets of LRV Nobody thought analyzing paint meant diving into light reflectance values (LRV), but that's precisely where we're headed today. Painting a room seems simple until you realize your color choice might turn your bright haven into a cave or vice versa. Thanks to some insights from Wendy Anguiano in HelloNation, let's dig into this technical...

Extend Your Water Heater's Life with Anode Care

Small Component, Big Impact: The Anode Rod Picture this: You’ve got a trusty water heater keeping your showers steamy, but lurking inside is a villain called rust. Enter the unsung hero—the anode rod. It might not be glamorous, but this little piece of metal works overtime to save your tank from a watery grave. Tim Fessler and Dave Super, seasoned plumbing hotshots...

Orthocell's Remplir™ Hits Record U.S. Sales in October

Orthocell's October Surprise with Remplir™ Sales Well, isn't this a breath of fresh air? Orthocell Limited just reported a staggering rise in its U.S. Remplir™ sales for October 2026. We're talking 92 units shifting off the shelves, pulling in a tidy AU$279,000. That's an 84% leap compared to the average monthly sales of 50 units in Q1 FY27. It seems the company's...

Smart Salary Moves for S Corp Owners: Riggs Unpacks Insights

Decoding the S Corp Salary Dance How much salary should the savvy owners of S corporations draw? It ain't a simple task or one-size-fits-all deal, folks. David Riggs spills the beans on HelloNation, sharing insights on this complex tango between drawing wages and raking in shareholder distributions. In the end, it’s about playing by the IRS rules—or risking a penalty...

CPC's Rigorous Self-Governance Balances Power Effectively

What's the Deal With Those Ancient Quotes? There's nothing like a quote from the Warring States Period to set the stage for good ol' fashioned governance chatter. Lu Buwei's words about rulers and compass points is historic, sure, but it speaks to the core need for standards in today's China. This isn't just some fortune cookie wisdom; it's a clarion call for order and...